MarketPeel
Insider Trading Intelligence
LS

Lawrence Steinman

BCAB
DIRECTOR · BIOATLA, INC. · CIK 0001132679
FILING MIX · LIFETIME85%/15%
BUYS
23
SELLS
4
TOTAL VALUE
$266.3K
COMPANIES
2
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
231,242
AVG SELL PX
$36.43
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Lawrence Steinman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+57.14%+0.51%+0.07%+0.45%+4.93%
14d7+57.14%+2.11%+0.55%+1.56%-0.00%
30d7+71.43%-6.72%+0.97%-7.69%-8.06%
60d7+85.71%-10.00%+3.53%-13.53%-29.20%
90d7+85.71%-20.76%+3.10%-23.86%-36.96%
180d7+57.14%-57.82%+2.44%-60.94%-74.03%
1y7(1 pending)+66.67%-64.51%+1.29%-65.80%-65.32%
2y7(1 pending)+83.33%+236.87%+15.59%+221.28%-95.89%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCAB · 78,459 shares · as of Jun 18, 2025
019,61539,23058,84478,4592022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 23 buys / 4 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
152,783152,783May 1, 2026May 5, 2026View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASE
133,333$0.75$100.0K199,691Nov 28, 2025Dec 1, 2025View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
242,913242,913Oct 24, 2025Oct 27, 2025View →
BCAB
BIOATLA, INC.
PURCHASEGRANT
Stock grant
23,50078,459Jun 18, 2025Jun 18, 2025View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
7,5007,500Mar 1, 2024Mar 1, 2024View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
7,5007,500Mar 1, 2024Apr 5, 2024View →
BCAB
BIOATLA, INC.
PURCHASE
20,000$2.05$41.0K38,459Dec 19, 2023Dec 19, 2023View →
BCAB
BIOATLA, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 14, 2023Jun 15, 2023View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASE
30,000$0.43$12.9K1,327,174Jun 2, 2023Jun 6, 2023View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$0.98$4.9K1,287,174Nov 28, 2022Nov 28, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$0.99$5.0K1,282,174Nov 22, 2022Nov 22, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$1.10$5.5K1,277,174Oct 26, 2022Oct 26, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
1,000$1.14$1.1K1,263,174Oct 17, 2022Oct 17, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
9,000$1.13$10.2K1,272,174Oct 17, 2022Oct 17, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$1.00$5.0K1,272,174Jun 29, 2022Jun 30, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$1.02$5.1K1,267,174Jun 28, 2022Jun 30, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$1.00$5.0K1,262,174Jun 27, 2022Jun 27, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
5,000$1.00$5.0K1,257,174Jun 23, 2022Jun 23, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
652,1741,252,174Jun 21, 2022Jun 22, 2022View →
BCAB
BIOATLA, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jun 16, 2022Jun 17, 2022View →
BCAB
BIOATLA, INC.
SALE
450$30.00$13.5K18,459Nov 2, 2021Nov 3, 2021View →
BCAB
BIOATLA, INC.
SALE
450$36.82$16.6K18,909Sep 15, 2021Sep 17, 2021View →
BCAB
BIOATLA, INC.
SALE
450$40.60$18.3K19,359Aug 16, 2021Aug 18, 2021View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
100,000100,000Aug 2, 2021Jun 22, 2022View →
BCAB
BIOATLA, INC.
SALE
450$38.29$17.2K19,809Jul 15, 2021Jul 19, 2021View →
BCAB
BIOATLA, INC.
PURCHASEGRANT
Stock grant
12,30712,307Jun 15, 2021Jun 16, 2021View →
BCAB
BIOATLA, INC.
PURCHASE
5,38820,259Jun 14, 2021Jun 16, 2021View →
Other insiders · BCAB
Loading peer insiders…
About this filer
CIK 0001132679
ROLE
Director
PRIMARY
BCAB
COMPANIES
2
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001132679DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback